EQT reports Q2 results today with positioning largely unchanged from the previews published earlier this week — shorts remain thin, borrow is exceptionally loose, and options are sitting close to neutral.
Short interest edged down 0.4% on July 20 to 22.4 million shares, or 3.6% of the free float — well within normal territory and still below the brief spike to 22.7 million seen on July 16. Borrow availability is extraordinarily loose at 2,245%, meaning more than twenty-two shares are available to lend for every one currently borrowed. Cost to borrow has actually eased week-on-week, now running below 0.39% — a level that imposes no friction on new short positions. The ORTEX short score at 36.5 places EQT firmly in the lower half of the 0-100 range, with no meaningful squeeze pressure in the lending market. EQT gained 1.5% Tuesday, though it remains down about 2% over the past month at $49.80, underperforming close peers RRC and NOG, which both posted gains on the week.
The analyst community is still decisively bullish but has spent the past three weeks quietly lowering the bar. Morgan Stanley trimmed its target from $74 to $68 on June 29, and multiple Buy-rated firms — UBS, Jefferies, Stephens — have followed with modest cuts in July, all maintaining positive ratings. The consensus mean target of $67.12 implies roughly 35% upside from current levels, a gap that reflects genuine disagreement about the near-term commodity price outlook rather than structural doubt about EQT's position. Bulls point to the company's Appalachian scale, cost discipline, and growing demand from data centers and LNG exports as durable tailwinds. Bears counter with leverage risk, single-region concentration, and the ever-present threat of a natural gas price retreat denting cash flow and EBITDA. Valuation is undemanding — the stock trades at roughly 11.7x trailing earnings and 6.4x EV/EBITDA — which limits the downside case but also reduces the urgency for re-rating without a positive operational catalyst.
BlackRock added 7.6 million shares as of June 30, lifting its stake to 9.7% of shares outstanding — the largest holder by a wide margin. T. Rowe Price also added 5.2 million shares in the same period. That institutional accumulation offers a structural support floor, though CEO Toby Rice sold roughly $5.3 million of stock in early June, the most significant insider disposal in the 90-day window, which tempers the conviction read somewhat.
Today's print is less about whether EQT is growing and more about whether production volumes and realized prices can close the gap between a $49.80 stock and a Street consensus target that has been steadily retreating toward it.
See the live data behind this article on ORTEX.
Open EQT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
